1. Home
  2. ABEO vs EM Comparison

ABEO vs EM Comparison

Compare ABEO & EM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABEO
  • EM
  • Stock Information
  • Founded
  • ABEO 1974
  • EM 2017
  • Country
  • ABEO United States
  • EM China
  • Employees
  • ABEO N/A
  • EM N/A
  • Industry
  • ABEO Biotechnology: Pharmaceutical Preparations
  • EM Other Consumer Services
  • Sector
  • ABEO Health Care
  • EM Consumer Discretionary
  • Exchange
  • ABEO Nasdaq
  • EM Nasdaq
  • Market Cap
  • ABEO 350.2M
  • EM 286.5M
  • IPO Year
  • ABEO 1980
  • EM 2021
  • Fundamental
  • Price
  • ABEO $6.88
  • EM $1.33
  • Analyst Decision
  • ABEO Strong Buy
  • EM Hold
  • Analyst Count
  • ABEO 6
  • EM 1
  • Target Price
  • ABEO $18.17
  • EM $1.25
  • AVG Volume (30 Days)
  • ABEO 687.8K
  • EM 2.0M
  • Earning Date
  • ABEO 08-14-2025
  • EM 09-16-2025
  • Dividend Yield
  • ABEO N/A
  • EM N/A
  • EPS Growth
  • ABEO N/A
  • EM N/A
  • EPS
  • ABEO 0.99
  • EM N/A
  • Revenue
  • ABEO $400,000.00
  • EM $259,541,587.00
  • Revenue This Year
  • ABEO N/A
  • EM $3.30
  • Revenue Next Year
  • ABEO $339.63
  • EM $5.26
  • P/E Ratio
  • ABEO $7.02
  • EM N/A
  • Revenue Growth
  • ABEO N/A
  • EM N/A
  • 52 Week Low
  • ABEO $3.93
  • EM $0.50
  • 52 Week High
  • ABEO $7.54
  • EM $1.45
  • Technical
  • Relative Strength Index (RSI)
  • ABEO 56.13
  • EM 71.16
  • Support Level
  • ABEO $6.74
  • EM $1.13
  • Resistance Level
  • ABEO $7.05
  • EM $1.33
  • Average True Range (ATR)
  • ABEO 0.26
  • EM 0.05
  • MACD
  • ABEO -0.03
  • EM 0.00
  • Stochastic Oscillator
  • ABEO 30.95
  • EM 55.86

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.

About EM Smart Share Global Limited

Smart Share Global Ltd is a consumer tech company providing mobile device charging services through an extensive online and offline network in China. It provides service through power banks, placed in POIs operated by location partners, such as entertainment venues, restaurants, shopping centers, hotels, transportation hubs, and public spaces. Geographically, the company generates revenue from the PRC. The company has two segments, the mobile device charging segment and the PV business segment. The company generates the majority of its revenue from the mobile device charging segment.

Share on Social Networks: